Reference
The Harvard Drug Group, LLC Issues Voluntary Nationwide Recall of Dronabinol Capsules, USP, 2.5 mg and Ziprasidone Hydrochloride Capsules, 20 mg Due to Label Mix-up Internet Document : 14 Jun 2023. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/harvard-drug-group-llc-issues-voluntary-nationwide-recall-dronabinol-capsules-usp-25-mg-and
Rights and permissions
About this article
Cite this article
Harvard Drug Group label mix-up: dronabinol and ziprasidone capsules recalled. Reactions Weekly 1962, 2 (2023). https://doi.org/10.1007/s40278-023-41672-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-41672-0